Narayana Hrudayalaya Ltd
Narayana Hrudalaya Ltd is engaged in providing economical healthcare services. It has a network of multispecialty and super specialty hospitals spread across multiple locations.[1]
- Market Cap ₹ 25,722 Cr.
- Current Price ₹ 1,259
- High / Low ₹ 1,445 / 1,080
- Stock P/E 33.0
- Book Value ₹ 157
- Dividend Yield 0.32 %
- ROCE 26.5 %
- ROE 31.4 %
- Face Value ₹ 10.0
Pros
- Company has delivered good profit growth of 67.8% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 30.9%
Cons
- Stock is trading at 8.03 times its book value
- Tax rate seems low
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Part of BSE 250 SmallCap Index Nifty Smallcap 50 Nifty Smallcap 250 Nifty Smallcap 100 BSE Allcap
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
839 | 1,095 | 1,364 | 1,614 | 1,878 | 2,281 | 2,861 | 3,128 | 2,583 | 3,701 | 4,525 | 5,018 | 5,224 | |
769 | 989 | 1,236 | 1,434 | 1,642 | 2,064 | 2,566 | 2,694 | 2,394 | 3,038 | 3,538 | 3,845 | 4,038 | |
Operating Profit | 70 | 106 | 128 | 180 | 236 | 217 | 295 | 434 | 189 | 664 | 987 | 1,173 | 1,186 |
OPM % | 8% | 10% | 9% | 11% | 13% | 10% | 10% | 14% | 7% | 18% | 22% | 23% | 23% |
28 | 39 | 6 | -19 | 7 | 18 | 16 | 7 | 21 | 26 | 59 | 70 | 89 | |
Interest | 19 | 31 | 45 | 33 | 28 | 55 | 81 | 94 | 82 | 76 | 84 | 112 | 122 |
Depreciation | 46 | 57 | 68 | 76 | 80 | 100 | 137 | 186 | 184 | 183 | 210 | 242 | 255 |
Profit before tax | 34 | 57 | 21 | 51 | 135 | 80 | 93 | 161 | -56 | 430 | 752 | 889 | 898 |
Tax % | 29% | 38% | 71% | 59% | 39% | 36% | 37% | 26% | -75% | 20% | 19% | 11% | |
24 | 29 | -19 | 21 | 83 | 51 | 59 | 119 | -14 | 342 | 607 | 790 | 779 | |
EPS in Rs | 762.14 | 974.49 | -0.84 | 1.04 | 4.06 | 2.51 | 2.90 | 5.82 | -0.70 | 16.73 | 29.67 | 38.62 | 38.10 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 35% | 17% | 0% | 6% | 8% | 10% |
Compounded Sales Growth | |
---|---|
10 Years: | 16% |
5 Years: | 12% |
3 Years: | 25% |
TTM: | 7% |
Compounded Profit Growth | |
---|---|
10 Years: | 51% |
5 Years: | 68% |
3 Years: | 365% |
TTM: | 6% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 33% |
3 Years: | 29% |
1 Year: | 1% |
Return on Equity | |
---|---|
10 Years: | 17% |
5 Years: | 24% |
3 Years: | 31% |
Last Year: | 31% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 0.33 | 0.33 | 200 | 204 | 204 | 204 | 204 | 204 | 204 | 204 | 204 | 204 | 204 |
Reserves | 547 | 580 | 568 | 672 | 759 | 831 | 877 | 932 | 916 | 1,284 | 1,927 | 2,679 | 3,001 |
256 | 333 | 362 | 258 | 217 | 802 | 813 | 952 | 826 | 723 | 884 | 1,627 | 1,703 | |
160 | 242 | 241 | 424 | 468 | 692 | 746 | 813 | 833 | 931 | 1,155 | 1,123 | 1,334 | |
Total Liabilities | 963 | 1,156 | 1,371 | 1,557 | 1,648 | 2,529 | 2,640 | 2,901 | 2,779 | 3,143 | 4,170 | 5,633 | 6,243 |
620 | 738 | 913 | 1,054 | 1,082 | 1,848 | 1,838 | 2,092 | 1,961 | 1,980 | 2,336 | 2,651 | 3,068 | |
CWIP | 44 | 20 | 20 | 14 | 53 | 35 | 56 | 12 | 20 | 67 | 259 | 514 | 737 |
Investments | 7 | 51 | 52 | 87 | 96 | 9 | 17 | 86 | 120 | 132 | 252 | 844 | 911 |
292 | 346 | 385 | 402 | 417 | 637 | 729 | 711 | 678 | 964 | 1,323 | 1,624 | 1,528 | |
Total Assets | 963 | 1,156 | 1,371 | 1,557 | 1,648 | 2,529 | 2,640 | 2,901 | 2,779 | 3,143 | 4,170 | 5,633 | 6,243 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
45 | 110 | 77 | 174 | 219 | 182 | 279 | 443 | 304 | 485 | 1,085 | 1,067 | |
-147 | -168 | -223 | -150 | -146 | -520 | -162 | -189 | -113 | -267 | -1,176 | -1,458 | |
108 | 57 | 140 | 18 | -45 | 315 | -27 | -247 | -194 | -159 | 88 | 488 | |
Net Cash Flow | 6 | -1 | -6 | 42 | 28 | -22 | 89 | 7 | -2 | 59 | -4 | 97 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 40 | 45 | 38 | 34 | 30 | 45 | 34 | 31 | 39 | 43 | 35 | 31 |
Inventory Days | 60 | 64 | 56 | 48 | 45 | 56 | 48 | 35 | 32 | 30 | 31 | 42 |
Days Payable | 121 | 198 | 146 | 152 | 173 | 200 | 177 | 177 | 221 | 180 | 224 | 205 |
Cash Conversion Cycle | -21 | -90 | -51 | -70 | -98 | -100 | -95 | -111 | -150 | -108 | -158 | -132 |
Working Capital Days | 10 | 2 | -3 | -2 | -9 | -4 | -8 | -17 | -17 | -0 | -11 | -9 |
ROCE % | 5% | 8% | 7% | 9% | 14% | 9% | 9% | 14% | 2% | 25% | 32% | 27% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
14 Nov - Of schedule of investor meeting to be held on November 19 2024
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 13 Nov
- Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011 13 Nov
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 13 Nov
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
11 Nov - Of schedule of investor meeting to be held on November 12 2024
Annual reports
Concalls
-
Nov 2024Transcript PPT
-
Aug 2024TranscriptPPT
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT REC
-
Feb 2024Transcript PPT REC
-
Nov 2023Transcript PPT REC
-
Aug 2023Transcript PPT REC
-
May 2023TranscriptPPT
-
May 2023Transcript PPT
-
May 2023TranscriptNotesPPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
Aug 2022TranscriptNotesPPT
-
May 2022Transcript PPT
-
Feb 2022Transcript PPT
-
Dec 2021TranscriptPPT
-
Nov 2021TranscriptNotesPPT
-
Aug 2021TranscriptNotesPPT
-
Jun 2021Transcript PPT
-
Feb 2021Transcript PPT
-
Nov 2020Transcript PPT
-
Nov 2020TranscriptNotesPPT
-
Aug 2020Transcript PPT
-
Aug 2020TranscriptNotesPPT
-
Jun 2020TranscriptNotesPPT
-
Feb 2020Transcript PPT
-
Nov 2019Transcript PPT
-
Aug 2019Transcript PPT
-
Jun 2019Transcript PPT
-
Feb 2019Transcript PPT
-
Nov 2018Transcript PPT
-
Aug 2018Transcript PPT
-
Jun 2018Transcript PPT
-
Feb 2018Transcript PPT
-
Jan 2018TranscriptNotesPPT
-
Nov 2017Transcript PPT
-
Aug 2017Transcript PPT
-
May 2017TranscriptNotesPPT
-
Nov 2016TranscriptPPT
-
Jul 2016TranscriptPPT
-
May 2016TranscriptNotesPPT
Business
Company provides healthcare services and operates a chain of multi specialty, tertiary, and primary healthcare facilities. As of Q3 FY24, it has a network of 18 hospitals and 3 heart centers across India along with overseas presence at Cayman Islands, with ~5,640 operational beds and a capacity of ~6,040 beds[1]